PPMX
Perseus Proteomics is a biopharmaceutical company that develops PPMX-T003 drugs to treat blood cancers for individuals.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed PPMX Information
Geographic Data
Address: Meguro
City: Tokyo
State: tōkyō prefecture
Zip: 153-0041
Country: JP
Financial Info
Stage:
series unknown
Raised Last:
$1M
Raised Total:$1M
Social
Metrics
4,080,016Website Global Rank
2,883Website Monthly Traffic
Twitter Followers
Description
Perseus Proteomics is a biopharmaceutical company that develops PPMX-T003 drugs to treat blood cancers for individuals.
Contact Phone:
Contact Email:
PPMX went public on the Tokyo Stock Exchange
Listed Exchange:
Tokyo Stock Exchange
Ticker Symbol:
4882
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
